期刊文献+

百里醌抑制体外骨肉瘤细胞转移的实验研究 被引量:3

An Experimental Study on Anti-metastasis Effect of Thymoquinone on the Osteosarcoma SaOS-2 Cell Line in Vitro
下载PDF
导出
摘要 目的:探讨百里醌抑制体外骨肉瘤细胞转移的作用及其机制。方法:本研究应用不同浓度百里醌作用人骨肉瘤Sa OS-2细胞后,观察百里醌对体外骨肉瘤Sa OS-2细胞迁移和侵袭的作用;Western blotting检测骨肉瘤细胞中MMP-2和MMP-9表达的变化。结果:百里醌可呈浓度依赖性抑制体外人骨肉瘤骨肉瘤Sa OS-2细胞迁移和侵袭,同时百里醌可下调骨肉瘤Sa OS-2细胞中MMP-2和MMP-9的表达。结论:百里醌可抑制体外骨肉瘤细胞转移,该作用可能通过下调MMP-2和MMP-9的表达而实现。 Objective: To investigate the anti-metastasis effect and its mechanism of thymoquinone on the osteosarcoma SeeS-2 cell line in vitro.Method: In the study, after application of different concentrations of thymoquinone in the role of human osteosarcoma SaOS-2 cells, the effects of thymoquinone on the migration and invasion of osteosarcoma SeeS-2 cells were examined by using wound assay and matrigel counting.Western blotting was used to detect the protein expression of MMP-2 and MMP-9 in SeeS-2 cells.Result: Thymoquinone significantly suppressod the migration and invaaion of osteosarcoma SaOS-2 cells in a concentration depended manner,The expression of MMP-2 and MMP-9 were down-regulated in osteosarcoma SaOS-2 cells after treatment of thymoquinone,Conclusion: Thymoquinone exerts anti-metastatic activity in SaOS-2 cells in vitro, which may be achieved by down-regulating the expression of MMP-2 and MMP-9.
作者 周齐
出处 《中国医学创新》 CAS 2016年第5期26-29,共4页 Medical Innovation of China
关键词 骨肉瘤 百里醌 转移 Osteosarcoma Thymoquinone Metastasis
  • 相关文献

参考文献15

  • 1Ikezoe T,Chen S S,Heber D,et al.Baicalin is a major component of PC-SPES which inhibits the proliferation of human cancer cells via apoptosis and cell cycle arrest[J].Prostate,2001,49(4):285-292.
  • 2崔侨,田代真一,小野寺敏,池岛乔.冬凌草甲素通过诱导人宫颈癌HeLa细胞自噬下调凋亡的机制[J].药学学报,2007,42(1):35-39. 被引量:20
  • 3Zhang J F,Liu J J,Liu P Q,et al.Oridonin inhibits cell growth by induction of apoptosis on human hepatocelluar carcinoma BEL-7402 cells[J].Hepatol Res,2006,35(2):104-110.
  • 4Leung C H,Grill S P,Lam W,et al.Novel mechanism of inhibition of nuclear factor-kappa B DNA-binding activity by diterpenoids isolated from Isodon rubescens[J].Mol Pharmacol,2005,68(2):286-297.
  • 5Ahmad I,Muneer K M,Tamimi I A,et al.Thymoquinone suppresses metastasis of melanoma cells by inhibition of NLRP3inflammasome[J].Toxicol Appl Pharmacol,2013,270(1):70-76.
  • 6Torres M P,Ponnusamy M P,Chakraborty S,et al.Effects of thymoquinone in the expression of mucin 4 in pancreatic cancer cells:implications for the development of novel cancer therapies[J].Mol Cancer Ther,2010,9(5):1419-1431.
  • 7Li X T,Lin C,Li P Y.Characteristics of the cytostatic effects of oridonin in vitro[J].Acta Pharmacol Sin,1986,7(4):361-363.
  • 8Cavallaro U,Christofori G.Multitasking in tumor progression:signaling functions of cell adhesion molecules[J].Ann N Y Acad Sci,2004,1(1014):58-66.
  • 9安爱军,郑永刚,曹晶杰.三种双膦酸盐治疗恶性肿瘤骨转移骨痛的成本-效果分析[J].中国医学创新,2013,10(22):57-58. 被引量:4
  • 10常娜,吴韦炜,徐成胜,钱立庭.重组人p53腺病毒联合化疗治疗颈部转移癌的临床疗效观察[J].中国医学创新,2013,10(17):3-4. 被引量:1

二级参考文献71

共引文献46

同被引文献32

  • 1王运林,廖二元,戴如春,向光大,肖新华,罗湘杭.17β-雌二醇对人骨肉瘤MG-63细胞株IL-6、IL-11和NF-κB表达的作用[J].中国现代医学杂志,2005,15(24):3710-3714. 被引量:3
  • 2Moore D D, Luu H H.Osteosarcoma[J].Cancer Treat Res, 2014, 162 (4) : 65-92.
  • 3Hung G Y, Yen H J, Yen C C, et al.Improvement in high-grade osteosarcoma survival : results from 202 patients treated at a single institution in Taiwan[J].Medicine ( Baltimore ), 2016, 95 ( 15 ) : e3420.
  • 4Kim J, Woo H Y, Kim E K, et al.Metastatic osteosarcoma to the breast presenting as a densely calcified mass on mammography[J].J Breast Cancer, 2016, 19 ( 1 ) : 87-91.
  • 5Xiao H, Chen L, Luo G, et al.Effect of the cytokine levels in serum on osteosarcoma[J].Tumour Biol, 2014, 35 ( 2 ) : 1025- 1028.
  • 6Yao X, Huang J, Zhong H, et al.Targeting interleukin-6 in inflammatory autoimmune diseases and cancers[J].Pharmacol Ther, 2014, 141 (2) : 125-139.
  • 7Lin Y M, Chang Z L, Liao Y Y, et al.IL-6 promotes ICAM-1 expression and cell motility in human osteosarcoma[J].Cancer Lett, 2013, 328 ( 1 ) : 135-143.
  • 8Kami~ska K, Czarnecka AM, Escudier B, et al.Interleukin-6 as an emerging regulator of renal cell cancer[J].Urol Oncol, 2015, 33 ( 11 ) : 476-485.
  • 9Vignali D A, Kuehroo V K.IL-12 family cytokines: immunological playmakers[J].Nat Immunol, 2012, 13 (8) : 722-728.
  • 10Jones L L, Chaturvedi V, Uyttenhove C, et al.Distinct subunit pairing criteria within the heterodimeric IL-12 cytokine family[J]. MolImmunol, 2012, 51 (2) : 234-244.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部